Re: Spec question

I agree that the hazard statement domain does not make sense in
    subjectScheme maps. Nonetheless, that domain was included in the
    subjectScheme shells that OASIS shipped for 1.2. Trust both the spec
    and the DTDs.

    

    Personally, I always remove the hazard statement and mapgroup
    domains from subjectScheme document-type shells when I create them
    for clients. And often the utilities and highlighting domain as
    well.

    

    
Best,

      Kris

      

      Kristen James Eberlein

      Chair, OASIS DITA Technical Committee

      Principal consultant, Eberlein Consulting

      www.eberleinconsulting.com

      +1 919 682-2290; kriseberlein (skype)

      

    

    
On 5/28/2015 9:01 AM, Julio Vazquez
      wrote:

    

    
      
      
      
      

        
Hi Kris,

        
 

        
We’re having an internal discussion about
          Vasont configuration and are looking at SubjectScheme maps. I
          think there’s some confusion about the containment statements
          in the spec and I’d like to get some clarity to help my case.
          For example, the contains by statement for hazardstatement  (http://docs.oasis-open.org/dita/v1.2/os/spec/langref/hazardstatement.html#hazardstatement)
          would have you believe that a hazardstatement can appear
          directly in the SubjectScheme map. 

        
 

        
From a logical viewpoint, this makes no
          sense because a hazardstatement is a topic construct, not a
          map construct. Of course, following the domain inclusions in
          the DTD, it should be allowable within the map. 

        
 

        
So the question becomes should I trust the
          spec or the mod file for the actual configuration of Vasont?

        
 

        
Julio
            J. Vazquez

        
Senior Content
            Analyst

        
Vasont
              Systems
            

        
A
              TransPerfect
            Company 

        
Skype:
              tpt_jvazquez

        
 

        
+1
            717-793-3895

        
www.vasont.com

        
The
              information in this email is confidential and intended for
              those to whom it is addressed.